| Literature DB >> 23407614 |
Kotaro Kitaya1, Tadahiro Yasuo.
Abstract
Chronic endometritis (CE) is an unusual endometrial inflammation characterized by stromal plasmacyte infiltration. CE is easily missed due to its subtle symptoms and demanding histopathological examinations. Although the immunohistochemistry for the plasmacyte marker CD138 has facilitated the detection of endometrial stromal plasmacytes, the accuracy and biases of this method for CE diagnosis remain poorly understood. The aim of this study was to investigate the inter- and intra-observer variability in the immunohistochemical detection of stromal plasmacytes in the human endometrium. A total of 80 CE and 20 non-pathological archival hematoxylin-stained endometrial preparations with or without immunostaining for CD138 were evaluated independently by two experienced observers and two inexperienced observers. Endometrial stromal plasmacytes in unit areas were counted in the hematoxylin-stained and CD138-immunostained preparations. Each preparation was subdivided into 11 categories by every five plasmacyte counts. The second evaluation was performed four weeks after the first evaluation. The immunohistochemical detection method was superior to conventional histopathological evaluation in both the inter- and intra-observer agreement, irrespective of the experience level of the observers. The linear weighted κ coefficient for intra-observer agreement was higher in the experienced observers than in the inexperienced observers. The inter-observer agreement among the four observers by the immunohistochemical detection method was similarly good between the first and second evaluation. There was no significant inter- or intra-observer variability in the paired comparison of the individual samples. These findings validate the use of immunohistochemistry for CD138 as an accurate and less biased diagnostic tool for CE.Entities:
Keywords: CD138; chronic endometritis; inter-observer agreement; intra-observer agreement; plasmacyte
Year: 2012 PMID: 23407614 PMCID: PMC3570187 DOI: 10.3892/etm.2012.824
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Representative inter-observer agreement (between experienced observer 1 and inexperienced observer 3) on endometrial stromal CD138+ plasmacyte density by the immunohistochemical method.
| Endometrial stromal CD138+ plasmacyte density: observer 1 (experienced): | Endometrial stromal CD138+ plasmacyte density: observer 3 (inexperienced)
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0–4 | 5–9 | 10–14 | 15–19 | 20–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45–49 | ≥50 | |
| 0–4 | 16 | ||||||||||
| 5–9 | |||||||||||
| 10–14 | |||||||||||
| 15–19 | |||||||||||
| 20–24 | |||||||||||
| 25–29 | |||||||||||
| 30–34 | |||||||||||
| 35–39 | |||||||||||
| 40–44 | |||||||||||
| 45–49 | |||||||||||
| ≥50 | |||||||||||
Plasmacyte density was calculated as immunoreactive cell counts in 20 non-overlapping stromal areas and subdivided into 11 categories by every five cell counts. Bold numbers indicate the number of cases where the two independent observers agreed on the presence of CE. Underlined numbers indicate the number of cases where the two observers disagreed on the CE diagnosis. Numbers that are neither bold nor underlined indicate the numbers of cases where the two independent observers agreed on the absence of CE.
Linear weighted κ values for inter-observer variability of the first endometrial stromal CD138+ plasmacyte density evaluation using the immunohistochemical method and conventional histopathological method (in parenthesis).
| Observer | Observer 1 | Observer 2 | Observer 3 |
|---|---|---|---|
| Observer 2 | 0.976 (0.771) | - | - |
| Observer 3 | 0.973 (0.701) | 0.968 (0.719) | - |
| Observer 4 | 0.973 (0.725) | 0.968 (0.729) | 0.973 (0.641) |
Representative intra-observer agreement (within the results for inexperienced observer 4) on endometrial stromal CD138+ plasmacyte density.
| Endometrial stromal CD138+ plasmacyte density: observer 4 (first evaluation) | Endometrial stromal CD138+ plasmacyte density: observer 4 (second evaluation)
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0–4 | 5–9 | 10–14 | 15–19 | 20–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45–49 | ≥50 | |
| 0–4 | 17 | ||||||||||
| 5–9 | |||||||||||
| 10–14 | |||||||||||
| 15–19 | |||||||||||
| 20–24 | |||||||||||
| 25–29 | |||||||||||
| 30–34 | |||||||||||
| 35–39 | |||||||||||
| 40–44 | |||||||||||
| 45–49 | |||||||||||
| ≥50 | |||||||||||
Bold numbers indicate the number of cases where the observer diagnosed the presence of CE in the first and second evaluation. Underlined numbers indicate the number of cases where the CE diagnosis at the first and second evaluations did not agree. Numbers that are neither bold nor underlined indicate the number of cases where the observer diagnosed the absence of CE in the first and second evaluations.
Linear weighted κ values for intra-observer variability of endometrial stromal CD138+ plasmacyte density evaluation using the immunohistochemical method and conventional histopathological method (in parenthesis).
| Second evaluation
| ||||
|---|---|---|---|---|
| First evaluation | Observer 1 | Observer 2 | Observer 3 | Observer 4 |
| Observer 1 | 0.965 (0.649) | - | - | - |
| Observer 2 | - | 0.968 (0.658) | - | - |
| Observer 3 | - | - | 0.933 (0.477) | - |
| Observer 4 | - | - | - | 0.939 (0.515) |